Evidence map›Paper›PMID 34489765›Full record

ArticleFrontiers in psychiatry2021

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.

Sam Mostafa, Thomas M Polasek, Leslie J Sheffield, David Huppert, Carl M J Kirkpatrick

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmacogenomics ofPharmaceutics · 2025
    Article
  5. Article
  6. Article
  7. Observational
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Evaluation ofMetabolites · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sam MostafaCentre for Medicine Use and Safety, Monash University, Parkville, VIC, Australia.
Thomas M PolasekCentre for Medicine Use and Safety, Monash University, Parkville, VIC, Australia.
Leslie J SheffieldMyDNA Life, Australia Limited, South Yarra, VIC, Australia.
David HuppertDepartment of Aged & Liaison Psychiatry, Alfred Health, Melbourne, VIC, Australia.
Carl M J KirkpatrickCentre for Medicine Use and Safety, Monash University, Parkville, VIC, Australia.
Melbourne Health · AUMonash University · AURoyal Adelaide Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CYP2C19CYP2C9CYP2D6pharmacogenomicsphenoconversion

Identifiers

PMID34489765
PMCPMC8416898
OpenAlexW3193549734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.